Russia is to create a 300 billion ruble (US$4 billion) anti-crisis fund to try to shield its economy from the effects of the COVID-19 pandemic, Russian Prime Minister Mikhail Mishustin said yesterday.
Moscow has said it might miss its growth targets this year and global markets have been bruised by the impact of the virus.
A sharp drop in the price of oil, Russia’s main export, has left Russia particularly vulnerable, with the rouble sinking to four-year lows against the US dollar.
The Russian Ministry of Finance and the Russian central bank have already pledged support to everything from the banking sector to the rouble and the state debt market, and attention is now focused on a key interest rate meeting set for Friday.
New support measures would include tax breaks for tourism companies and airlines, and that Russia would expand its preferential loans program for businesses, Mishustin said.
Andrei Belousov, his first deputy, last week said that Russia might miss its economic growth target this year, originally set at 2 percent, while economists have warned that the country’s economy might turn negative amid low oil prices and slower business activity.
Russia has 63 confirmed COVID-19 cases and is building a new hospital outside Moscow to prepare for a possible increase in numbers. That is in addition to a hospital that was recently converted to treat coronavirus patients only.
There have been no deaths from the virus in Russia so far, authorities say.
Russia is already restricting passenger flights and has halted many trains to Europe.
Russia would close its border with Belarus as well, Mishustin said.
Russia has recommended that institutions of higher education switch to distance learning, while the city of Moscow has made school attendance optional.
There have been some signs of panic buying. Shelves over the weekend in a number of Moscow shops were lacking toilet paper, washing powder and canned products, as well as rice and flour.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS